2 (Current trial type: compatible, incompatible) × 2 (Coronal: frontal, frontal-central) × 3 (Sagittal: left, midline, right) HLMs. Mean amplitudes as a function of beverage group, previous trial accuracy, and compatibility are displayed in Table 2, and Figures 3 and 4 display stimulus-locked waveforms in which the N2 and FSW are indicated. Note that because all ERP components examined here represent negative voltage deflections, larger magnitude is associated with more negative amplitude values.
